Donor desmopressin is associated with superior graft survival after kidney transplantation

Transplantation

Volumn 92, Issue 11, 2011, Pages 1252-1258

  Benck, Urs ^a   Gottmann, Uwe ^a   Hoeger, Simone ^a   Lammert, Alexander ^a   Rose, Daniela ^a   Boesebeck, Detlef ^b   Lauchart, Werner ^c   Birck, Rainer ^a   Weiss, Christel ^a   Krämer, Bernhard K ^a   Yard, Benito A ^a   Schnuelle, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Organ Procurement Organization of Bavaria   (Germany)

^c Organ Procurement Organization of Baden Württemberg   (Germany)

Author keywords

Brain dead donor; Endothelium; Graft survival; Renal transplantation; Reperfusion injury

Indexed keywords

CALCINEURIN INHIBITOR; CD25 ANTIBODY; CD3 ANTIBODY; CELL ANTIBODY; CORTICOSTEROID; DESMOPRESSIN; DIURETIC AGENT; DOPAMINE; INSULIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NORADRENALIN; PLASMA SUBSTITUTE; PREDNISOLONE; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BRAIN DEATH; COHORT ANALYSIS; COLD ISCHEMIA; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DRUG EXPOSURE; EUROPE; FEMALE; GRAFT PRESERVATION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY ALLOGRAFT REJECTION; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; BIOPSY; COHORT STUDIES; COLD ISCHEMIA; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INCIDENCE; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 81855164609     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318236cd4c     Document Type: Article

References (32)

1. Novitzky D, Cooper DK, Rosendale JD, et al. Hormonal therapy of the brain-dead organ donor: Experimental and clinical studies. Transplantation 2006; 82: 1396.
2. Rosendale JD, Chabalewski FL, McBride MA, et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002; 2: 761.
3. Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: A randomized controlled trial. JAMA 2009; 302: 1067.
4. Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006. Rockville, MD: Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation 2007.
5. Osterlee A, Rahmel A. Annual Report Eurotransplant International Foundation, 2007, p. 32.
6. Van der Hoeven JA, Molema G, Ter Horst GJ, et al. Relationship between duration of brain death and hemodynamic (in)stability on progressive dysfunction and increased immunologic activation of donor kidneys. Kidney Int 2003; 64: 1874.
7. Wood KE, Becker BN, McCartney JG, et al. Care of the potential organ donor. N Engl J Med 2004; 351: 2730.
8. Richardson DW, Robinson AG. Desmopressin. Ann Intern Med 1985; 103: 228.
9. Augustin HG, Koh GY, Thurston G, et al. Control of vascular morphogenesis and homeostasis through the Angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009; 10: 165.
10. Hirschl MM, Matzner MP, Huber WO, et al. Effect of desmopressin substitution during organ procurement on early renal allograft function. Nephrol Dial Transplant 1996; 11: 173.
11. Guesde R, Barrou B, Leblanc I, et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet 1998; 352: 1178.
12. Desschans B, Van Gelder F, Van Hees D, et al. Evolution in allocation rules for renal, hepatic, pancreatic and intestinal grafts. Acta Chir Belg 2008; 108: 31.
13. Kaufmann JE, Oksche A, Wollheim CB, et al. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest 2000; 106: 107.
14. GoligorskyMS,Patschan D,KuoMC.Weibel-Palade bodies-Sentinels of acute stress. Nat Rev Nephrol 2009; 5: 423.
15. Pinsky DJ, Naka Y, Liao H, et al. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest 1996; 97: 493.
16. Wolff B, Burns AR, Middleton J, et al. Endothelial cell "memory" of inflammatory stimulation: Human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J Exp Med 1998; 188: 1757.
17. Takada M, Nadeau KC, Shaw GD, et al. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99: 2682.
18. Fiedler U, Reiss Y, Scharpfenecker M, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12: 235.
19. Koo DD, Welsh KI, Roake JA, et al. Ischemia/reperfusion injury in human kidney transplantation: An immunohistochemical analysis of changes after reperfusion. Am J Pathol 1998; 153: 557.
20. Opelz G, Dohler B. Multicenter analysis of kidney preservation. Transplantation 2007; 83: 247.
21. De Vries DK, Lindeman JHN, Ringers J, et al. Donor brain death predisposes human kidney grafts to a proinflammatory reaction after transplantation. Am J Transplant 2011; 11: 1064.
22. Qian Z, Gelzer-Bell R, Yang Sx SX, et al. Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection. Circulation 2001; 104: 2369.
23. Singbartl K, Green SA, Ley K. Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J 2000; 14: 48.
24. Nijboer WN, Schuurs TA, van der Hoeven JA, et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 2004; 78: 978.
25. Yard B, Beck G, Schnuelle P, et al. Prevention of cold-preservation injury of cultured endothelial cells by catecholamines and related compounds. Am J Transplant 2004; 4: 22.
26. Brinkkoetter PT, Song H, Lösel R, et al. Hypothermic injury: The mitochondrial calcium, ATP and ROS love-hate triangle out of balance. Cell Physiol Biochem 2008; 22: 195.
27. Brinkkoetter PT, Beck GC, Gottmann U, et al. Hypothermia-induced loss of endothelial barrier function is restored after dopamine pretreatment: Role of p42/p44 activation. Transplantation 2006; 82: 534.
28. Gottmann U, Brinkkoetter PT, Bechtler M, et al. Effect of pre-treatment with catecholamines on cold preservation and ischemia/reperfusioninjury in rats. Kidney Int 2006; 70: 321.
29. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statist Med 1998; 17: 2265.
30. Olsen EH,McCainAS, Merricks EP, et al. Comparative response of plasma VWF in dogs to up-regulation of VWF mRNA by interleukin-11 versus Weibel-Palade body release by Desmopressin (DDAVP). Blood 2003; 102: 436.
31. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41.
32. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Statist Assoc 1984; 79: 516.